Early hemodynamic and neurohormonal response after transcatheter aortic valve implantation

American Heart Journal

Volumn 160, Issue 5, 2010, Pages 862-869

  Sherif, Mohammad A ^a,b   Abdel Wahab, Mohamed ^a,b   Awad, Omar ^b   Geist, Volker ^a   El Shahed, Ghada ^b   Semmler, Reinhard ^a   Tawfik, Mazen ^b   Khattab, Ahmed A ^b   Richardt, Doreen ^c   Richardt, Gert ^a   Tölg, Ralph ^a  

^a Segeberger Kliniken GmbH   (Germany)

^b Ain Shams University Hospital   (Egypt)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

AGED; AORTA STENOSIS; AORTA VALVE; AORTA VALVE REPLACEMENT; ARTICLE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART HEMODYNAMICS; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURGICAL AORTIC VALVE REPLACEMENT; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BIOPROSTHESIS; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HEART VENTRICLES; HEMODYNAMICS; HUMANS; MALE; NATRIURETIC PEPTIDES; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 78649376716     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.07.017     Document Type: Article

References (26)

1. Vahanian A., Baumgartner H., and Bax J. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Eur Heart J 28 2007 230 268
2. Patel J.H., Mathew S.T., and Hennebry T.A. Transcatheter aortic valve replacement: a potential option for the nonsurgical patient Clin Cardiol 32 2009 296 301
3. Ikeda T., Matsuda K., and Itoh H. Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis Am Heart J 133 1997 307 314
4. Weber M., Hausen M., and Arnold R. Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis Heart 92 2006 1639 1644
5. Qi W., Mathisen P., and Kjekshus J. The effect of aortic valve replacement on N-terminal natriuretic propeptides in patients with aortic stenosis Clin Cardiol 25 2002 174 180
6. Gerber I.L., Stewart R.A., and Legget M.E. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis Circulation 107 2003 1884 1890
7. Qi W., Mathisen P., and Kjekshus J. Natriuretic peptides in patients with aortic stenosis Am Heart J 142 2001 725 732
8. Grube E., Schuler G., and Buellesfeld L. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome J Am Coll Cardiol 50 2007 69 76
9. Piazza N., Otten A., and Schultz C. Adherence to patient selection criteria in patients undergoing transcatheter aortic valve implantation with the 18F CoreValve ReValving System Heart 96 2010 19 26
10. de Jaegere P., van Dijk L.C., and Laborde J.C. True percutaneous implantation of the CoreValve aortic valve prosthesis by the combined use of ultrasound guided vascular access, Prostar(R) XL and the TandemHeart(R) EuroIntervention 2 2007 500 505
11. Otto C.M., Pearlman A.S., and Comess K.A. Determination of the stenotic aortic valve area in adults using Doppler echocardiography J Am Coll Cardiol 7 1986 509 517
12. Devereux R.B., Alonso D.R., and Lutas E.M. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 57 1986 450 458
13. Zoghbi W.A., Enriquez-Sarano M., and Foster E. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography J Am Soc Echocardiogr 16 2003 777 802
14. Rahimtoola S.H. Valve prosthesis-patient mismatch: an update J Heart Valve Dis 7 1998 207 210
15. Nashef S.A., Roques F., and Michel P. European System for Cardiac Operative Risk Evaluation (EuroSCORE) Eur J Cardiothorac Surg 16 1999 9 13
16. De Jaegere P.P., Piazza N., and Galema T.W. Early echocardiographic evaluation following percutaneous implantation with the self-expanding CoreValve ReValving System aortic valve bioprosthesis EuroIntervention 4 2008 351 357
17. Gegouskov V.A., Eckstein F.S., and Kipfer B. The Sorin pericardial bioprosthesis-a stentless aortic valve with very good hemodynamic performance Swiss Surg 9 2003 247 252
18. Clavel M.A., Webb J.G., and Pibarot P. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis J Am Coll Cardiol 53 2009 1883 1891
19. Rahimtoola S.H. Is severe valve prosthesis-patient mismatch (VP-PM) associated with a higher mortality? Eur J Cardiothorac Surg 30 2006 1
20. Piazza N., Grube E., and Gerckens U. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval EuroIntervention 4 2008 242 249
21. Rallidis L.S., Moyssakis I.E., and Ikonomidis I. Natural history of early aortic paraprosthetic regurgitation: a five-year follow-up Am Heart J 138 1999 351 357
22. Caballero-Borrego J., Gomez-Doblas J.J., and Cabrera-Bueno F. Incidence, associated factors and evolution of non-severe functional mitral regurgitation in patients with severe aortic stenosis undergoing aortic valve replacement Eur J Cardiothorac Surg 34 2008 62 66
23. Chin D. Echocardiography for transcatheter aortic valve implantation Eur J Echocardiogr 10 2009 i21 9
24. Talwar S., Downie P.F., and Squire I.B. Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis Eur J Heart Fail 3 2001 15 19
25. Liska B., Khattab A.A., and Sherif M.A. Clinical and hemodynamic predictors of natriuretic peptide elevation among aortic valve disease patients Int J Cardiol 2009 10.1016/j.ijcard.2008.12.211 [E-pub ahead of print]
26. Neverdal N.O., Knudsen C.W., and Husebye T. The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis-one year follow-up Eur J Heart Fail 8 2006 257 262